Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 415.00
Bid: 410.00
Ask: 420.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.439%)
Open: 415.00
High: 415.00
Low: 415.00
Prev. Close: 415.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Update, Capital Allocation and Dividend Policy

11 May 2020 07:00

RNS Number : 3670M
Science Group PLC
11 May 2020
 

 

 

 

11 May 2020

 

 

 

 

 

AGM Update, Capital Allocation and Dividend Policy

 

 

The Annual Report for the year ended 31 December 2019, together with the notice of the Annual General Meeting of the Company ("AGM"), will be posted to shareholders on 15 May 2020 and will be available on the Group's website shortly thereafter.

 

As announced on 31 March 2020, the AGM will be held at the Group's London office on 16 June 2020. In the current exceptional circumstances, the meeting will only address formal matters, have only sufficient attendees to be quorate and will not provide any opportunity for questions. In accordance with UK Government guidelines on gatherings, the Board requests that shareholders do not attend and that all shareholders appoint the Chairman of the meeting as their proxy.

 

Capital Allocation and Dividend Policy

 

Despite the wider impact of the Covid-19 pandemic on the business environment, Science Group's financial performance continues to be in line with the Board's expectations prior to the outbreak. As set out on 31 March 2020 and 4 May 2020, the Board has not revised its expectations and the Group remains both profitable and cash generative. Furthermore, the Group benefits from a strong balance sheet with net cash and significant freehold property assets.

 

However, prudence is an important consideration in the current unpredictable climate and the Board has therefore continued to consider the appropriateness of paying a dividend at the present time, whilst also evaluating the best use of capital resources in the long-term interests of all stakeholders. In this regard, the Board has consulted with the Group's major shareholders.

 

In particular, the Board has considered the acquisitive strategy of the Group and the potential benefits to be derived from increasing the scale of Science Group through opportunities for corporate development which may arise in the months ahead. The Board also recognises that the pandemic has exacerbated the lack of liquidity in small cap shares.

 

In summary, the Board has concluded that, at the present time, the Company's best long-term interests are served by:

 

(i) Not recommending a dividend at the AGM, but to consider an interim dividend later in the financial year if appropriate;

 

(ii) Subject to approval of the resolutions at the AGM to renew the buy-back facility, to provide market liquidity through share buy-backs as appropriate; and

 

(iii) To continue to evaluate opportunities to deploy capital resources to increase the scale of the Group in line with the Board's strategic plans.

 

The resolutions to be put to shareholders at the AGM will reflect the above conclusions.

 

 

 

Science Group plc

 

Martyn Ratcliffe, Chairman

Rebecca Archer, Finance Director

Tel: +44 (0) 1223 875 200

www.sciencegroup.com

 

 

Panmure Gordon

 

Nominated Adviser: Dominic Morley, Alina Vaskina

Corporate Broking: Erik Anderson

Tel: +44 (0) 20 7886 2500

 

 

 

MHP Communications (PR Advisor to Science Group)

 

Reg Hoare, James Bavister, Pete Lambie

Tel: +44 (0) 20 3128 8100

 

sciencegroup@mhpc.com

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAZZGMKLGVGGZM
Date   Source Headline
12th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20237:00 amRNSHolding(s) in Company
2nd Aug 202312:34 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSTotal Voting Rights
28th Jul 20237:00 amRNSTreasury shares issued & PDMR dealing
27th Jul 20237:00 amRNSTreasury shares issued
24th Jul 20237:00 amRNSInterim results for 6 months ended 30 June 2023
18th Jul 20231:35 pmRNSNotice of Interim Results
13th Jul 20237:00 amRNSHolding(s) in Company
12th Jun 20234:33 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSTransaction in Own Shares
18th May 202311:50 amRNSResult of AGM
18th May 20237:00 amRNSAGM Trading and Board Update
15th May 20237:00 amRNSIssue of share options & PDMR dealing
12th May 20232:05 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Share & Total Voting Rights
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSPosting of documents and Notice of AGM
12th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
16th Mar 20231:00 pmRNSNotice of Preliminary Results
14th Mar 20234:45 pmRNSHolding(s) in Company
14th Mar 20233:00 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSStatement re banking arrangements
13th Mar 20237:00 amRNSBanking Arrangements
2nd Mar 20233:06 pmRNSHolding(s) in Company
10th Feb 20231:20 pmRNSHolding(s) in Company
9th Feb 20232:45 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSCompletion of Sale of Westek Technology Ltd
31st Jan 202312:25 pmRNSHolding(s) in Company
31st Jan 202311:35 amRNSHolding(s) in Company
26th Jan 202310:05 amRNSScheme Effective
24th Jan 20232:21 pmRNSCourt Sanction of Scheme of Arrangement
9th Jan 20237:00 amRNSRegulatory Clearance & Scheme Timetable Update
15th Dec 20227:00 amRNSPre-Close Trading and Business Update
14th Dec 20223:33 pmRNSResult of Court Meeting & General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.